1. TLR4 promoted endoplasmic reticulum stress induced inflammatory bowel disease via the activation of p38 MAPK pathway
- Author
-
Tian Hu, Yan Zhao, Yan Long, Xiaoqing Ma, Ya Zeng, Weijie Wu, Chongtian Deng, Mengling Li, Siyuan Peng, Hanzhi Yang, Mi Zhou, Jinyue Hu, and Yueming Shen
- Subjects
Inflammation ,Lipopolysaccharides ,Tumor Necrosis Factor-alpha ,Interleukin-8 ,Biophysics ,Cell Biology ,Endoplasmic Reticulum Stress ,Inflammatory Bowel Diseases ,p38 Mitogen-Activated Protein Kinases ,Biochemistry ,Toll-Like Receptor 4 ,Mice ,Animals ,lipids (amino acids, peptides, and proteins) ,Molecular Biology ,Signal Transduction - Abstract
Endoplasmic reticulum (ER) stress contribute to inflammatory bowel disease (IBD). However, the mechanistic link between toll-like receptor 4 (TLR4) and ER stress in IBD remains elusive. This study aimed to investigate the mechanism by which ER stress and TLR4 promote inflammation in IBD. IBD mouse model was established by the induction of TNBS, and Grp78 and TLR4 in intestine tissues were detected by immunohistochemistry. THP-1 cells were treated with lipopolysaccharides (LPS), ER stress inducer or inhibitor tauroursodeoxycholic acid (TUDCA), or p38 MAPK inhibitor. The activation of MAPK signaling was detected by Western blot, and the production and secretion of inflammatory factors were detected by PCR and ELISA. We found that the expression levels of TLR4 and GRP78 were significantly higher in the intestine of IBD model mice compared with control mice but were significantly lower in the intestine of IBD model mice treated with ER stress inhibitor TUDCA. ER stress inducer significantly increased while ER stress inhibitor TUDCA significantly decreased the expression and secretion of TNF-α, IL-1β and IL-8 in THP-1 cells treated by LPS. Only p38 MAPK signaling was activated in THP-1 cells treated by ER stress inducer. Furthermore, p38 inhibitor SB203580 inhibited the production and secretion of TNF-α, IL-1β and IL-8 in THP-1 cells treated with LPS. In conclusion, TLR4 promotes ER stress induced inflammation in IBD, and the effects may be mediated by p38 MAPK signaling. TLR4 and p38 MAPK signaling are novel therapeutic targets for IBD.
- Published
- 2022